Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

PCV13 [pneumococcal 13-valent conjugate vaccine], or cohort 3: PPSV23 followed by or preceded by PCV13, PPSV23 preceded by PCV15 [pneumococcal 15-valent conjugate vaccine], or PCV15 alone).

The pneumococcal conjugate vaccine – codenamed PCV21/GBP410 – has started pivotal trials in the prevention of both paediatric Streptococcus pneumoniae, which remains a major public health ...

To protect your child, their doctor will give them the pneumococcal conjugate vaccine (PCV ... was approved in 2000, and ...

Healthcare providers, public health officials and policymakers need to develop a greater understanding of the serious health impact of pneumococcal disease in elderly adults. In addition to ...

Expanded recommendations from the Advisory Committee on Immunization Practices on the use of pneumococcal conjugate vaccines may improve disease ... older who have started their vaccine series with ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

After the introduction of pneumococcal conjugate vaccine (PCV)-7 ... in antimicrobial resistance and MDR in S. pneumoniae. PCV13 may contribute in reducing the spread of drug-resistant 19A ...

IBM has leased around 1.1 lakh square feet of office space from Table Space at DivyaSree Greens, a custom-made campus located in Bengaluru, sources told HT.com. IBM has leased approximately 1.1 ...